pre-IPO PHARMA
COMPANIES VC JOBS NEWS CONTACT

COMPANY OVERVIEW

NorthSea Therapeutics is a clinical-stage biotech company developing first-in-class, oral, structurally engineered fatty acid therapeutics.

LOCATION

  • Naarden, , The Netherlands

    • THERAPEUTIC AREAS

  • Fibrotic DIsease

  • Inflammatory Disease

  • Metabolic Disorders

    • WEBSITE

    https://www.northseatherapeutics.com/

    CAREER WEBSITE

    None

    SOCIAL MEDIA

    INVESTORS

    bgv forbion new-science-ventures novo-seeds sofinnova-investments venbio

    PRESS RELEASES


    Jan 5, 2023

    NorthSea Therapeutics Provides Clinical Update Reflecting Progress Across NASH And Metabolic Disorders Programmes


    Dec 21, 2022

    NorthSea Therapeutics Appoints Morris J. Birnbaum to the Board


    Feb 2, 2022

    NorthSea Therapeutics Initiates Phase 1 Trial of SEFA-6179, Targeting the Orphan Indication Intestinal Failure-Associated Liver Disease


    Dec 17, 2021

    NorthSea Therapeutics Completes US$80 Million Series C Fundraising to Advance Clinical Programs in Metabolic Disorders


    Nov 19, 2020

    NorthSea Therapeutics doses first patient in Phase 1 trial of SEFA-1024 in dyslipidemia and further expands its clinical pipeline


    For More Press Releases
    Google Analytics Alternative